InnovaDerma (LON:IDP), the UK developer of life sciences, beauty and personal care products, said it has now launched Prolong - the world's only FDA-cleared medical device for premature ejaculation - in the United States and Australia.
The Skinny Tan group said the launch is being supported by a highly creative marketing campaign, including a website smilingdick.com.
READ: InnovaDerma remains confident in spite of Superdrug decision
InnovaDerma said it conducted in-depth research with 4,000 men and women across Australia and the United States and the findings form the basis of the launch of Prolong and smilingdick.com.
It added that the most revealing findings were that one in two men in the United States believe they suffer from premature ejaculation and in Australia, one in three.
The company said it is seeking CE Mark regulatory approval for Prolong and once obtained, the device will also be launched in the UK and Europe.
Haris Chaudhry, InnovaDerma’s executive chairman said: "I am delighted to be launching Prolong, the world's only FDA-cleared medical device for premature ejaculation in the United States and Australia together with smilingdick.com.”
He added: “Through Prolong and Smiling Dick, we aim to provide a non-prescription solution with long term benefits and a platform to help people feel open and supported in what should be a healthy and normal dialogue."